O
0.798
0.02 (2.31%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 看涨 |
| Biotechnology (全球的) | 混合的 | 看涨 | |
| 股票 | Oncolytics Biotech Inc. | 混合的 | 看涨 |
AIStockmoo 评分
-0.7
| 分析师共识 | NA |
| 内部交易活动 | NA |
| 价格波动 | 0.5 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | -2.5 |
| 平均 | -0.67 |
|
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Value |
| 内部持股比例 | 3.92% |
| 机构持股比例 | 1.53% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Sandbox Financial Partners, Llc | 31 Mar 2026 | 400,000 |
| Seeds Investor Llc | 30 Jun 2026 | 258,306 |
| International Assets Investment Management, Llc | 30 Jun 2026 | 201,260 |
| Connective Capital Management, Llc | 30 Jun 2026 | 185,712 |
| Tocqueville Asset Management L.P. | 30 Jun 2026 | 147,000 |
| Everhart Financial Group, Inc. | 30 Jun 2026 | 140,899 |
| Pfg Investments, Llc | 30 Jun 2026 | 128,300 |
| Doliver Advisors, Lp | 30 Jun 2026 | 100,000 |
| Lpl Financial Llc | 30 Jun 2026 | 80,316 |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合